Cargando…
Treatment Needs and Rates of Mental Health Comorbidity in Adolescent Patients With ARFID
The purpose of this paper is to provide a descriptive overview of a single-center ARFID-specific pilot clinic that sought to better understand the specific needs of patients with ARFID including rates of comorbidities, and to gain insight into treatment requirements. A retrospective cohort study was...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327955/ https://www.ncbi.nlm.nih.gov/pubmed/34349680 http://dx.doi.org/10.3389/fpsyt.2021.680298 |
_version_ | 1783732209644994560 |
---|---|
author | Norris, Mark L. Obeid, Nicole Santos, Alexandre Valois, Darcie D. Isserlin, Leanna Feder, Stephen Spettigue, Wendy |
author_facet | Norris, Mark L. Obeid, Nicole Santos, Alexandre Valois, Darcie D. Isserlin, Leanna Feder, Stephen Spettigue, Wendy |
author_sort | Norris, Mark L. |
collection | PubMed |
description | The purpose of this paper is to provide a descriptive overview of a single-center ARFID-specific pilot clinic that sought to better understand the specific needs of patients with ARFID including rates of comorbidities, and to gain insight into treatment requirements. A retrospective cohort study was completed on patients meeting criteria for ARFID admitted to a specialized pilot clinic within a tertiary care hospital. Over an 18 month period, a total of 26 patients were assessed and had follow-up data for a 12 month period. Patients presented with heterogeneous manifestations of ARFID and high rates of comorbid mood and anxiety disorders were noted. Treatment plans were tailored to meet individual needs at assessment and over the treatment period. A multidisciplinary approach was most often administered, including a combination of individual therapy, family therapy, medical monitoring, and prescribed medications. Only 30% of patients were treated exclusively by therapists on the eating disorder team. The experiences gained from this pilot study highlight the need for specialized resources for assessment and treatment of patients with ARFID, the importance of a multidisciplinary approach to treatment, and the necessity of utilization of ARFID-specific measures for program evaluation purposes. |
format | Online Article Text |
id | pubmed-8327955 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83279552021-08-03 Treatment Needs and Rates of Mental Health Comorbidity in Adolescent Patients With ARFID Norris, Mark L. Obeid, Nicole Santos, Alexandre Valois, Darcie D. Isserlin, Leanna Feder, Stephen Spettigue, Wendy Front Psychiatry Psychiatry The purpose of this paper is to provide a descriptive overview of a single-center ARFID-specific pilot clinic that sought to better understand the specific needs of patients with ARFID including rates of comorbidities, and to gain insight into treatment requirements. A retrospective cohort study was completed on patients meeting criteria for ARFID admitted to a specialized pilot clinic within a tertiary care hospital. Over an 18 month period, a total of 26 patients were assessed and had follow-up data for a 12 month period. Patients presented with heterogeneous manifestations of ARFID and high rates of comorbid mood and anxiety disorders were noted. Treatment plans were tailored to meet individual needs at assessment and over the treatment period. A multidisciplinary approach was most often administered, including a combination of individual therapy, family therapy, medical monitoring, and prescribed medications. Only 30% of patients were treated exclusively by therapists on the eating disorder team. The experiences gained from this pilot study highlight the need for specialized resources for assessment and treatment of patients with ARFID, the importance of a multidisciplinary approach to treatment, and the necessity of utilization of ARFID-specific measures for program evaluation purposes. Frontiers Media S.A. 2021-07-16 /pmc/articles/PMC8327955/ /pubmed/34349680 http://dx.doi.org/10.3389/fpsyt.2021.680298 Text en Copyright © 2021 Norris, Obeid, Santos, Valois, Isserlin, Feder and Spettigue. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Norris, Mark L. Obeid, Nicole Santos, Alexandre Valois, Darcie D. Isserlin, Leanna Feder, Stephen Spettigue, Wendy Treatment Needs and Rates of Mental Health Comorbidity in Adolescent Patients With ARFID |
title | Treatment Needs and Rates of Mental Health Comorbidity in Adolescent Patients With ARFID |
title_full | Treatment Needs and Rates of Mental Health Comorbidity in Adolescent Patients With ARFID |
title_fullStr | Treatment Needs and Rates of Mental Health Comorbidity in Adolescent Patients With ARFID |
title_full_unstemmed | Treatment Needs and Rates of Mental Health Comorbidity in Adolescent Patients With ARFID |
title_short | Treatment Needs and Rates of Mental Health Comorbidity in Adolescent Patients With ARFID |
title_sort | treatment needs and rates of mental health comorbidity in adolescent patients with arfid |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327955/ https://www.ncbi.nlm.nih.gov/pubmed/34349680 http://dx.doi.org/10.3389/fpsyt.2021.680298 |
work_keys_str_mv | AT norrismarkl treatmentneedsandratesofmentalhealthcomorbidityinadolescentpatientswitharfid AT obeidnicole treatmentneedsandratesofmentalhealthcomorbidityinadolescentpatientswitharfid AT santosalexandre treatmentneedsandratesofmentalhealthcomorbidityinadolescentpatientswitharfid AT valoisdarcied treatmentneedsandratesofmentalhealthcomorbidityinadolescentpatientswitharfid AT isserlinleanna treatmentneedsandratesofmentalhealthcomorbidityinadolescentpatientswitharfid AT federstephen treatmentneedsandratesofmentalhealthcomorbidityinadolescentpatientswitharfid AT spettiguewendy treatmentneedsandratesofmentalhealthcomorbidityinadolescentpatientswitharfid |